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Exosomes are microvesicles that are released from several different types of 
cells.15 Exosomes are thought to play an important role in functions such as immune 
regulation and coagulation; however their full functionality is not completely 
understood.8 Current research has started to explore their potential utilization in gene 
therapy and drug delivery. Their derivation from different proteins and RNA make them 
a versatile transport target in microbiology research.3,4,10 
Although exosomes are being increasingly used in current research for gene 
therapy applications, the actual mechanism is unknown once the exosomes are taken into 
the cells. Using microfluidic channels, the entire process of exosome uptake can be 
imaged and monitored. The design of the microfluidic device allows for the manipulation 
of cellular flow and imitates the real flow of cells during exosome uptake and 
interaction.18 The microfluidic device is made from a mold using polydimethylsiloxane 
(PDMS) and the channels are coated with fibronectin for the cells to adhere to. The 
device is plasma bonded to a thin sheet of PDMS, incubated, and then left to cure. 
Because of its ability to grow quickly and efficiently in less-than-ideal conditions, hey 
ovarian cancer cells are used to seed the device. The hey cells are seeded at a density 
between five million and 10 million cells in the device, and fresh media is pumped 
through the device. The cells are left to adhere and proliferate for between 24 hours while 
fresh media is passed through the device in the 37oC incubator. The hey cells are dyed 
using a DAPI fluorescent stain which causes the hey cells to illuminate blue fluorescence. 
Exosomes that are stained with PKH to illuminate green fluorescence are then seeded 
into the channels, and images are taken using confocal microscopy at several time points. 
The images showing blue fluorescent hey cells and green fluorescent exosomes are 
overlayed to show the exosomes uptake into the hey cells. Several images are taken 
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across approximately a 20-minute time period to show the interaction between the 
exosomes and the cells in the channels. 
Currently, images have been taken of the uptake of exosomes into the hey cells 
without a continuous flow in the channels. The time lapse of how the exosomes are taken 
into the cells in the microfluidic device channels can be observed, but the point of interest 
comes in the effect of flow on the exosome uptake. Future studies and plans look to 
observe a constant flow through the channel while the exosomes are seeded into the 
device. The effect of flow on the uptake as well as the observation of exosome 
breakdown after being taken into the cells will help to elucidate the potential of exosomes 









Exosomes are microvesicles initially thought to be the cell’s method of removing 
unwanted proteins from the cells, which is how the term “exosome” was coined.14 
However, exosomes have recently been found to play an important role in immune 
regulation as well as coagulation, intercellular signaling, and waste management. They 
are released by several different types of cells such as reticulocytes5, dendritic cells12, B 
cells8, T cells1, mast cells9, epithelial cells6, and tumour cells7. Although the exact 
function of exosomes is not known, evidence has shown that it can be used in specific 
targeting and signaling pathways in the cell.4 
Exosomes are generally about 30-120 nm in size and are composed of a lipid bilayer of 
functional biomolecules such as proteins, mRNA and miRNA. The structure allows for 
exosomes to be delivered to a target cell through fusion which also indicates its 
importance in cell-to-cell communication.13 Exosomes will contain proteins that are 
specific to the cell type that they are derived from.2  
 
Literature Review 
 The research of exosomes and their functionality has only recently become a topic 
of interest to scientists and researchers. Over 1500 papers about exosomes have been 
found on PubMed, all within the last 3 years. Basic functionality and biological functions 
have been explored by researchers, but there is still much unknown about exosomes, 
including, but not limited to, their mechanistic pathway and uptake into the cells. Because 
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they are derived from so many different types of cells, exosomes may be an important 
precursor to early gene therapy and cell-derived targeting.17 
 Exosomes show potential in delivering siRNA by using the body’s own 
intercellular “shuttle” for RNAs. Currently, lipids are the preferential vessel for siRNA 
delivery and efficient and specific delivery is achieved to the liver. However, this 
approach raises the concern of liver toxicity. Utilizing exosomes for siRNA delivery 
would alleviate toxicity and the need for additional methods to induce delivery since 
exosomes naturally embody intercellular communication.16 
 In terms of diagnostics, exosomes may help for early detection and diagnosis. As 
a specific example, research has been conducted exploring the microRNA signatures of 
exosomes and the microRNA-expression profiles of ovarian cancer tumor cells. By 
screening the exosomes from the patient, even subtle expressions may indicate early 
stages of ovarian cancer. In illnesses such as cancer, early detection may mean the 
difference between the patient’s survival and ease of treatment.11 
 Exosomes are not clearly understood, and as such their potential is currently 
untapped. As researchers work to understand their mechanism, functionality, and 
pathways of expression, the possible applications are numerous. This research would 
contribute to the ongoing understanding of the pathway and interaction with the cell to 
further gene therapy research. 
 3 
CHAPTER 2 
MATERIALS AND METHODS  
 
Materials 
For the PDMS construction, Sylgard® 184 Silicone Elastomer Curing Agent and 
Sylgard® 184 Silicone Elastomer Base is needed along with a vacuum desiccators and 
vortex machine to stir the compound thoroughly. Pipettes and bakers are used for 
accuracy. The device is placed in a 5.365 inch diameter petri dish. In order to seed the 
cells and pass media through, liquid fibronectin, 8% dextran, and sigmacote is needed to 
prepare the device for the cells to adhere and proliferate. Both larger and smaller tubing, 
0.020” ID x 0.060” OD and 0.012” ID x 0.030” OD respectively as well as a blunt point 
needle (20 gauge x ½”) to pump media through the device properly are needed. Standard 
cell culture procedure is used to passage the hey cells accordingly. A standard 37oC 
incubator is used to house the cells. When imaging, green PKH dye is used to stain the 
exosomes and DAPI is used to stain the hey cell nuclei.  
PDMS Construction 
 For this experiment, microfluidic devices were designed in a simple channel, and 
the mold was constructed using the nanotechnology clean room. The channels are 
intended to mimic real-condition flow.  
When mixing the polydimethylsiloxane (PDMS), a 10:1 (w/w) ratio of base to 
hardener is used. The air bubbles are removed using a vacuum desiccator, and the 
mixture is poured onto the mold for an approximate thickness of 5mm. The vacuum is 
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used once again to further remove any remaining air bubbles that may have resulted from 
the pour. The mixture is then either cured at 60o C or left to harden overnight. 
For this particular petri dish that has a 5.5 inch diameter and a thickness of 1 inch, 
in order to have the devices with a height of 0.500 cm, calculations for the volume are 
conducted in order to determine the amount of PDMS mixture necessary. The volume 
calculation is represented as a cylinder which gives . When plugging in the 
dimensions of the petri dish and the desired height, it can be determined that a volume of 
76.6006 mL of PDMS is needed. With the ratio mixture mentioned previously, it can be 
determined that 70 mL of base and 7 mL of hardener is needed for the mixture. 
The cured PDMS device is cut from the wafer mold using a knife or a scalpel. 
Inlet and outlet holes are punched in the device using a 1.0 mm hole punch and the 
surfaces are cleaned thoroughly with scotch tape. A thin sheet of PDMS or a microscope 
cover slip is used that is slightly larger than the PDMS device for bonding. One side of 
the PDMS device and the bonding material is exposed to oxygen plasma for 3 minutes, 
alternating the vacuum and oxygen for periods of 30 seconds each. The plasma knob is 
turned to High, and the observed color should be a light pink/purple. After the designated 
time, the vacuum seal is released and the bonded sides are placed together. The device is 
then placed on a hot plate for approximately 10-15 minutes to solidify the bonding.  
Cell Seeding 
Smaller tubing is then connected to a small length of larger tubing. A blunt-point 
needle of a syringe with 50 µg/mL of fibronectin is passed through the channels for cell 
adherence. The fibronectin is given between 40-60 minutes to coat the device’s channels. 
The large tubing is connected to a syringe with the blunt-point needle and the smaller 
tubing is inserted in the “inlet” hole in the PDMS device. Pressure is applied to the 
syringe to seed at a cell density between 5×106 and 8×106 cells. A fresh syringe with 
 5 
fresh media is connected to the device and left to pump fresh media through the channels 
at an approximate rate of 3 µL/min.  
 
 
Figure 1: Set-up of the protocol used to run the experiment. The mold is used to 
pour out the PDMS which is then placed in the vacuum dessicator to remove any air 
bubbles. The devices are then cut out from the hardened mold, and the devices are 
seeded with cells and left to proliferate. 
 





In order to image the live uptake of exosomes into the cell, the devices were 
imaged under a confocal microscope at 20x magnification. The hey cells were stained 
with a DAPI dye which would cause the nuclei to fluoresce blue. The exosomes that were 
extracted from the cells and labeled with a green PKH dyed were run through the 
channels and images were taken to see the live-time uptake of exosomes into the cells. In 
a matter of minutes (maximum of 20 minutes), the exosomes were completely taken into 
the cells.  
 
     






     
Figure 3: DAPI stained hey cells and PKH stained exosomes in microfluidic device 





Errors and Modifications 
Throughout this experiment, there were several setbacks and needs for 
modifications to the methods. The first experiment, the cells were seeded at density of 
approximately 2×106 cells/mL. The cells did not adhere or proliferate very well, and so it 
was determined that a higher density would be necessary, especially to obtain good 
confocal microscope images and to allow the cells to adhere and proliferate in the 
channels.  
The biggest issue came from false positive readings from the PKH dye. When 
imaging, the green dye was staining the actual PDMS of the device, causing a high 
reading of false positives for exosomes. In order to reduce the number of false positives, 
several alternatives were considered. First, it was decided to leave the dye to stain the 
exosomes for a longer period of time before adding them to the device. The idea was that 
this method would allow the dye to stick to the exosomes and not seep out into the PDMS 
channels of the device. Secondly, a side-by-side positive control would be conducted in 
order to “subtract out” the false positive readings and be able to tell which were the actual 
exosome readings. This would also allow for a direct comparison under the same 
microscope settings, which would also help if other issues arose. A third potential fix for 
the false positives would be insert a hey cell and exosome stained mixture together into 
an empty channel. This would cut down the time that the dye is exposed to the device, 
but the issue would arise in whether or not real time images could be obtained to see the 
actual uptake in the cells. The most fundamental fix would be to ensure that the threshold 
settings of the microscope are within the range that minimizes the number of false 
positive readings caused by the PKH dye (Appendix A). 
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Figure 5: Confocal microscope images 
of channels with PKH labeled exosome 
false positives. 
 
Figure 6: Confocal microscope images of 
channels with PKH labeled exosomes 
with adjusted settings to account for 
false positives. 
 
On the extreme, the dye could be changed possibly to a CDK red dye. Since the 
CDK dye is released intracellularly, the dye would not seep out into the channels. Also, 
the RFP cell line which has both the exosomes and cells could also be seeded onto the 
device to show the real time uptake of the exosomes, which would also solve the problem 





This experiment proves the utility of exosomes and the ease with which they are 
taken into the cells. Because they are derived from the cells, the exosomes are not 
identified as a foreign body which diminishes the immune response. The exosomes are 
biocompatible with the cell line they are being inserted back into, making it a potential 
gateway for gene therapy and possible drug delivery. More research is needed to explore 
the full uptake process as well as any negative results that may happen after the exosome 
is delivered. Because so little is known about exosomes and their functionality, there is 
potential for the exosome to play a major role in drug delivery and gene therapy, as well 





FUTURE PLANS  
 
In continuing this project, different cell lines could be explored in order to see the 
different uptake time and pathway. Images could be taken at different time points in order 
to compose a comprehensive timeline of exosome insertion and uptake. The most 
important next step would be to mimic real body conditions by incorporating a fluid flow 
of media. Additionally, future plans look to seed the devices with the RFP cell line to get 
a more real-time time scale of the uptake into the cell. 
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APPENDIX A 
IMAGING CONTROL THRESHOLD SETTINGS 
 
 When running the cell imaging with green PKH-labeled exosomes, the settings 
were taken at a gain of 793, offset of -30, and a digital gain of 0.3. The settings were 
altered in order to reduce the amount of false positives as mentioned in the discussion, 
and the threshold settings for the minimum false positive readings are a gain of 600, 
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